Perinatal Mental Health

Postpartum depression (PPD) is one of the most common complications after childbirth, affecting up to 1 in 7 new mothers. While many treatments exist, most traditional antidepressants take weeks to begin working—precious time when mothers are already struggling with sleep deprivation, hormonal changes, and the stress of caring for a newborn. That’s why the approval of zuranolone, the first fast-acting oral medication specifically designed for postpartum depression, represents an exciting new option for mothers seeking relief.

Zuranolone works differently from standard antidepressants. Instead of targeting serotonin, it acts on GABA receptors, the brain’s calming system responsible for regulating stress and mood. By enhancing this natural calming pathway, zuranolone can improve depressive symptoms quickly—often within 3 to 5 days. Many women begin feeling better while still taking the medication, rather than waiting weeks to notice improvements.

The treatment course is short: just one pill daily for 14 days, taken in the evening with a fatty meal to help absorption. This makes it a practical option for new mothers who may find long-term medications or complex schedules difficult to manage.

Like all medications, zuranolone has possible side effects. The most commonly reported include:

• Sleepiness or excessive drowsiness
• Dizziness
• Fatigue
• Headache
• Confusion or slowed thinking
• Dry mouth
• Nausea
• Balance problems

Because of the drowsiness risk, patients are advised not to drive or operate heavy machinery for at least 12 hours after taking each dose. It’s usually recommended to take zuranolone at night to reduce daytime sleepiness.

Breastfeeding considerations are important as well. Early studies show low levels of the medication in breast milk, but decisions about breastfeeding while taking zuranolone should be made together with your psychiatrist and pediatrician. For many mothers, a temporary breastfeeding pause may be appropriate, while others may continue with careful monitoring.

At Iroko Psychiatry, we help mothers understand whether zuranolone is a good option based on their symptoms, medical history, breastfeeding plans, and treatment goals. We provide comprehensive evaluations, close follow-up during the 14-day course, and ongoing support to make sure mothers feel safe, informed, and cared for. Whether used alone or alongside therapy, zuranolone can be a powerful tool for women who need faster relief from postpartum depression.

Postpartum depression is treatable, and you do not have to suffer in silence. If you think zuranolone might be right for you—or if you simply want to explore your options—we’re here to help you find a path toward recovery and emotional stability.

Many new mothers face a difficult dilemma: they want to continue breastfeeding, but they also need psychiatric medication to stay healthy, stable, and emotionally present for their baby. The good news is that for most women, breastfeeding and psychiatric treatment can safely coexist. With the right guidance, mothers can protect their mental health without giving up the benefits of breastfeeding.

Research shows that many antidepressants, mood stabilizers, and anxiety medications have been studied extensively in breastfeeding women. Medications like SSRIs (such as sertraline and paroxetine) are often considered first-line options because they produce extremely low levels in breast milk and have strong safety data. Other medications may be appropriate as well, depending on a mother’s medical history, current symptoms, and treatment goals. The key is individualized care—what is safe and effective for one mother may differ for another.

Mothers should also know that untreated mental health conditions carry risks for both mom and baby. Severe anxiety, depression, insomnia, or mood instability can impair bonding, lower milk supply, disrupt routines, and make the postpartum period far more challenging. In many cases, treating the mother’s mental health is the safest choice for the entire family. The goal is not medication vs. breastfeeding—it’s supporting both whenever possible.

If you are considering psychiatric medication while breastfeeding, here are some helpful tips:

Practical Tips for Mothers

• Discuss all options with your psychiatrist early—even during pregnancy if possible.
• Share your breastfeeding goals so your clinician can choose the safest, most compatible medication.
• Monitor your baby’s sleep, feeding, and weight patterns, especially in the first two months.
• Take medications after the longest sleep stretch, if recommended, to minimize infant exposure.
• Avoid abruptly stopping medication—withdrawal can worsen anxiety or depression.
• Keep your pediatrician in the loop, especially if your baby was premature or medically fragile.
• Trust the process—most babies exposed to psychiatric medications through breast milk do very well.

At Iroko Psychiatry, we help mothers navigate these decisions with clarity and confidence. We review each patient’s medical history, discuss medication options that are compatible with breastfeeding, and provide careful monitoring throughout the postpartum period. Whether through telepsychiatry or in-person visits, our team prioritizes both maternal mental health and infant safety. Your well-being matters—and taking care of yourself is one of the most powerful ways to care for your baby.

Postpartum depression (PPD) is far more common than many people realize. While it’s normal for new mothers to feel overwhelmed, emotional, or exhausted, PPD goes beyond the typical “baby blues.” It can involve persistent sadness, loss of interest in activities, difficulty bonding with the baby, irritability, guilt, or a sense of hopelessness. These symptoms can start during pregnancy or within the first year after childbirth, and they often make mothers feel as though they are failing—when in reality, they are experiencing a medical condition that deserves care and support.

PPD can affect any mother, regardless of age, background, or previous mental health history. Hormonal changes, lack of sleep, physical recovery after delivery, and emotional adjustments all play a role. Many women also struggle silently out of fear of being judged or misunderstood. It’s important to know that postpartum depression is not your fault. It does not mean you’re a bad mother, and it does not mean you don’t love your baby. It means your brain and body are under significant strain and need compassionate, evidence-based support.

Treatment for postpartum depression is highly effective. Many mothers benefit from a combination of therapy, medication, lifestyle adjustments, and structured emotional support. Therapies such as cognitive behavioral therapy (CBT) can help reframe negative thoughts, while antidepressant medications—many compatible with breastfeeding—can restore balance and significantly improve mood, sleep, and energy. The earlier PPD is recognized and treated, the easier it is to recover and regain a sense of connection and confidence.

At Iroko Psychiatry, we specialize in understanding the emotional challenges that arise after childbirth and provide warm, non-judgmental support to mothers navigating postpartum depression. Through in-person and telepsychiatry visits, we offer personalized treatment plans, medication management when needed, and ongoing follow-up to ensure recovery is steady and sustainable. Our goal is simple: to help mothers heal, reconnect with themselves, and fully enjoy life with their families. You are not alone, and help is available.

Bringing a new baby into the world is often described as joyful, transformative, and deeply emotional. But for many new mothers, the postpartum period also brings unexpected mental health challenges that are frightening, confusing, and difficult to talk about. One of these conditions is Postpartum Obsessive-Compulsive Disorder (Postpartum OCD)—a form of OCD that appears during pregnancy or after childbirth and is much more common than most people realize.

Postpartum OCD is not a sign of being a bad mother. It is not a predictor of harming your baby. And it is not something you caused. It is a treatable medical condition, and with the right support, women recover fully.

What Is Postpartum OCD?

Postpartum OCD involves intrusive, unwanted, and distressing thoughts—often about accidental or intentional harm befalling the baby. These thoughts feel terrifying and out of character. Mothers may become overwhelmed by:

Common Intrusive Thoughts

• “What if I drop the baby?”
• “What if I accidentally suffocate the baby while sleeping?”
• “What if I lose control and hurt the baby?”
• “What if I contaminate the baby with germs?”

These thoughts are ego-dystonic, meaning they go against your actual desires, values, and intentions. Mothers with postpartum OCD are typically very nurturing, cautious, and deeply bonded to their babies—yet the thoughts feel intrusive and unwanted.

Compulsions: The Behaviors That Follow

Many mothers try to neutralize or suppress these thoughts through repetitive behaviors, such as:

• Excessive checking (breathing, temperature, safety)
• Cleaning or handwashing repeatedly
• Avoiding being alone with the baby
• Removing objects they fear could cause harm
• Constantly seeking reassurance

These behaviors temporarily reduce anxiety but reinforce the cycle over time.

Why Does Postpartum OCD Happen?

Postpartum OCD stems from a combination of:

• Hormonal shifts
• Sleep deprivation
• Stress of caregiving
• Personal or family history of anxiety/OCD
• Perfectionism or high responsibility traits

It is a medical condition—not a failure of character or motherhood.

How Is Postpartum OCD Different From Psychosis?

This distinction is crucial:

• Postpartum OCD: Unwanted, intrusive thoughts the mother finds terrifying and inconsistent with her identity. She has insight and feels guilt and anxiety.
• Postpartum Psychosis: Loss of reality, delusions, hallucinations, and impaired judgment.

Most women with intrusive thoughts never harm their babies—because the thoughts are unwanted and cause distress.

Treatment: Highly Effective and Compassion-Centered

Postpartum OCD is very treatable, and early support leads to faster recovery.

Common treatments include:

‍

1. Cognitive Behavioral Therapy (CBT)‍

Featuring Exposure and Response Prevention (ERP)—the gold standard for OCD.

‍

2. Medication

SSRIs have strong evidence and are considered safe for many breastfeeding mothers.

‍

3. Sleep Support

Improving rest is often essential for symptom reduction.

‍

4. Partner and Family Education

Understanding the condition reduces shame and builds a supportive environment.

When to Seek Help

Reach out to a mental health professional if you notice:

• Intrusive thoughts that distress or frighten you
• Avoiding caregiving activities because of fear
• Repetitive behaviors that disrupt daily routines
• Intense guilt, shame, or fear of being alone with the baby

You deserve care that is compassionate, judgment-free, and knowledgeable about postpartum conditions.

How Iroko Psychiatry Can Help

At Iroko Psychiatry, we specialize in recognizing and treating postpartum OCD with respect, confidentiality, and evidence-based care. We know how isolating these experiences can feel, and we work closely with mothers to restore confidence, reduce distress, and support healthy bonding with their babies—whether through in-person visits or telepsychiatry.

You are not alone, and you can get better.

The period following childbirth can be a time of intense emotional change, and for many women it isn’t just the “baby blues.” Up to one in five—or possibly more—new mothers experience persistent and troubling anxiety. While some worry is natural, postpartum anxiety becomes a clinical concern when symptoms such as intrusive thoughts, excessive concern for the baby’s safety, restlessness, sleep disruption, and a sense of dread interfere with daily life and caregiving. Distressingly, this anxiety often appears alongside postpartum depression, meaning clinicians must routinely consider both mood and anxiety symptoms together rather than in isolation.

In managing such complex cases, evidence strongly supports an integrated, measurement-guided strategy. First-line pharmacotherapy typically involves selective serotonin reuptake inhibitors (SSRIs) because they address both depressive and anxiety symptoms. Clinical trials demonstrate that mothers with combined mood and anxiety concerns respond well to SSRIs—sometimes in tandem with cognitive behavioral therapy. For patients who do not sufficiently improve, serotonin‐norepinephrine reuptake inhibitors (SNRIs) can be considered, especially when anxiety symptoms are prominent. In severe cases—with debilitating insomnia, panic, obsessive stresses, or intrusive baby-related fears—a short‐term adjunctive benzodiazepine may provide vital sleep relief and symptom stabilization while the antidepressant takes effect.

Recent innovations also include rapid-acting agents that target both mood and anxiety symptoms in the postpartum period more directly. Importantly, early and repeated screening is critical: validated tools like the Edinburgh Postnatal Depression Scale (EPDS) should be paired with perinatal anxiety measures such as the PASS or the GAD-7. Screening should occur not only at the first postpartum visit but also during well-child checks at 1-, 2-, 4-, and 6-months. For mild to moderate cases, psychotherapy remains foundational—cognitive behavioral therapy, mindfulness-based approaches, and structured interventions can be highly effective and low-risk, particularly when used early.

At Iroko Psychiatry, our approach to postpartum mood and anxiety disorders is proactive, holistic, and personalized. We prioritize early identification, use measurement tools to track progress, and tailor our care plans to both the mother’s and infant’s needs. Whether delivered via telepsychiatry or in-clinic visits, our goal is the same: to ensure new mothers receive compassionate, comprehensive care, reduce the risk of chronic illness, and restore their ability to engage with their lives and families fully.